The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Lynn E. Sullivan

Department of Internal Medicine

Yale University School of Medicine

New Haven

CT 06520-8093

USA

[email]@yale.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8093, USA. 2004 - 2011

References

  1. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. Sullivan, L.E., Botsko, M., Cunningham, C.O., O'Connor, P.G., Hersh, D., Mitty, J., Lum, P.J., Schottenfeld, R.S., Fiellin, D.A. J. Acquir. Immune Defic. Syndr. (2011) [Pubmed]
  2. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Sullivan, L.E., Moore, B.A., O'Connor, P.G., Barry, D.T., Chawarski, M.C., Schottenfeld, R.S., Fiellin, D.A. Am. J. Addict (2010) [Pubmed]
  3. The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Sullivan, L.E., Saitz, R., Cheng, D.M., Libman, H., Nunes, D., Samet, J.H. Addiction (2008) [Pubmed]
  4. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. Sullivan, L.E., Moore, B.A., Chawarski, M.C., Pantalon, M.V., Barry, D., O'Connor, P.G., Schottenfeld, R.S., Fiellin, D.A. J. Subst. Abuse. Treat (2008) [Pubmed]
  5. Narrative review: buprenorphine for opioid-dependent patients in office practice. Sullivan, L.E., Fiellin, D.A. Ann. Intern. Med. (2008) [Pubmed]
  6. Training HIV physicians to prescribe buprenorphine for opioid dependence. Sullivan, L.E., Tetrault, J., Bangalore, D., Fiellin, D.A. Subst. Abus (2006) [Pubmed]
  7. A trial of integrated buprenorphine/naloxone and HIV clinical care. Sullivan, L.E., Barry, D., Moore, B.A., Chawarski, M.C., Tetrault, J.M., Pantalon, M.V., O'Connor, P.G., Schottenfeld, R.S., Fiellin, D.A. Clin. Infect. Dis. (2006) [Pubmed]
  8. Initial strategies for integrating buprenorphine into HIV care settings in the United States. Sullivan, L.E., Bruce, R.D., Haltiwanger, D., Lucas, G.M., Eldred, L., Finkelstein, R., Fiellin, D.A. Clin. Infect. Dis. (2006) [Pubmed]
  9. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Sullivan, L.E., Metzger, D.S., Fudala, P.J., Fiellin, D.A. Addiction (2005) [Pubmed]
  10. The prevalence and impact of alcohol problems in major depression: a systematic review. Sullivan, L.E., Fiellin, D.A., O'Connor, P.G. Am. J. Med. (2005) [Pubmed]
  11. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?. Sullivan, L.E., Chawarski, M., O'Connor, P.G., Schottenfeld, R.S., Fiellin, D.A. Drug. Alcohol. Depend (2005) [Pubmed]
  12. Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence. Sullivan, L.E., Fiellin, D.A. Clin. Infect. Dis. (2005) [Pubmed]
  13. Hepatitis C and HIV infections: implications for clinical care in injection drug users. Sullivan, L.E., Fiellin, D.A. Am. J. Addict (2004) [Pubmed]
 
WikiGenes - Universities